Nektar Therapeutics (NKTR) with a beta value of 0.60 appears to be a promising investment opportunity.
A new trading day began on Monday, with Nektar Therapeutics (NASDAQ: NKTR) stock price down -6.61% from the previous day of trading, before settling in